158 related articles for article (PubMed ID: 36612225)
1. Contemporary Trends in Malignant Peritoneal Mesothelioma: Incidence and Survival in the United States.
Calthorpe L; Romero-Hernandez F; Miller P; Conroy PC; Hirose K; Kim A; Kirkwood K; Nakakura E; Corvera C; Maker AV; Alseidi A; Adam MA
Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612225
[TBL] [Abstract][Full Text] [Related]
2. National Practice Patterns in Malignant Peritoneal Mesothelioma: Updates in Management and Survival.
Calthorpe L; Romero-Hernandez F; Casey M; Nunez M; Conroy PC; Hirose K; Kim A; Kirkwood K; Maker AV; Corvera C; Nakakura E; Alseidi A; Adam MA
Ann Surg Oncol; 2023 Aug; 30(8):5119-5129. PubMed ID: 37140748
[TBL] [Abstract][Full Text] [Related]
3. Malignant Pleural Mesothelioma Epidemiology in the United States From 2000 to 2016.
Thomas A; Karakattu S; Cagle J; Hoskere G
Cureus; 2021 Apr; 13(4):e14605. PubMed ID: 34040906
[TBL] [Abstract][Full Text] [Related]
4. An Investigation of Cancer-Directed Surgery for Different Histologic Subtypes of Malignant Pleural Mesothelioma.
Mansur A; Potter AL; Zurovec AJ; Nathamuni KV; Meyerhoff RR; Berry MF; Kang A; Jeffrey Yang CF
Chest; 2023 May; 163(5):1292-1303. PubMed ID: 36574925
[TBL] [Abstract][Full Text] [Related]
5. Impact of mesothelioma histologic subtype on outcomes in the Surveillance, Epidemiology, and End Results database.
Meyerhoff RR; Yang CF; Speicher PJ; Gulack BC; Hartwig MG; D'Amico TA; Harpole DH; Berry MF
J Surg Res; 2015 Jun; 196(1):23-32. PubMed ID: 25791825
[TBL] [Abstract][Full Text] [Related]
6. Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival.
Verma V; Sleightholm RL; Rusthoven CG; Koshy M; Sher DJ; Grover S; Simone CB
Ann Surg Oncol; 2018 Jul; 25(7):2018-2026. PubMed ID: 29721724
[TBL] [Abstract][Full Text] [Related]
7. Current trends in the management of malignant peritoneal mesothelioma.
Miura JT; Johnston FM; Gamblin TC; Turaga KK
Ann Surg Oncol; 2014 Nov; 21(12):3947-53. PubMed ID: 24841356
[TBL] [Abstract][Full Text] [Related]
8. Malignant peritoneal mesothelioma: prognostic factors and oncologic outcome analysis.
Magge D; Zenati MS; Austin F; Mavanur A; Sathaiah M; Ramalingam L; Jones H; Zureikat AH; Holtzman M; Ahrendt S; Pingpank J; Zeh HJ; Bartlett DL; Choudry HA
Ann Surg Oncol; 2014 Apr; 21(4):1159-65. PubMed ID: 24322529
[TBL] [Abstract][Full Text] [Related]
9. Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival.
Verma V; Ahern CA; Berlind CG; Lindsay WD; Shabason J; Sharma S; Culligan MJ; Grover S; Friedberg JS; Simone CB
Clin Lung Cancer; 2018 Nov; 19(6):e901-e912. PubMed ID: 30224273
[TBL] [Abstract][Full Text] [Related]
10. Malignant Peritoneal Mesothelioma: Patterns of Care and Survival in the Netherlands: A Population-Based Study.
de Boer NL; van Kooten JP; Damhuis RAM; Aerts JGJV; Verhoef C; Madsen EVE
Ann Surg Oncol; 2019 Dec; 26(13):4222-4228. PubMed ID: 31620941
[TBL] [Abstract][Full Text] [Related]
11. Clinical-pathological characteristics and prognostic factors for malignant peritoneal mesothelioma in the elderly.
Pan D; Wang M; Liu W; Li Y; Sang L; Chang B
BMC Gastroenterol; 2022 Jun; 22(1):292. PubMed ID: 35681152
[TBL] [Abstract][Full Text] [Related]
12. Treatment patterns and outcomes for patients with malignant pleural mesothelioma in England in 2013-2017: A nationwide CAS registry analysis from the I-O Optimise initiative.
Baas P; Daumont MJ; Lacoin L; Penrod JR; Carroll R; Venkatesan S; Ubhi H; Calleja A; Snee M
Lung Cancer; 2021 Dec; 162():185-193. PubMed ID: 34823894
[TBL] [Abstract][Full Text] [Related]
13. Determinants of Survival in Malignant Pleural Mesothelioma: A Surveillance, Epidemiology, and End Results (SEER) Study of 14,228 Patients.
Taioli E; Wolf AS; Camacho-Rivera M; Kaufman A; Lee DS; Nicastri D; Rosenzweig K; Flores RM
PLoS One; 2015; 10(12):e0145039. PubMed ID: 26660351
[TBL] [Abstract][Full Text] [Related]
14. Patterns in the incidence, mortality and survival of malignant pleural and peritoneal mesothelioma, New South Wales, 1972-2009.
Soeberg MJ; Creighton N; Currow DC; Young JM; van Zandwijk N
Aust N Z J Public Health; 2016 Jun; 40(3):255-62. PubMed ID: 26713662
[TBL] [Abstract][Full Text] [Related]
15. Is There a Role for Cancer-Directed Surgery in Early-Stage Sarcomatoid or Biphasic Mesothelioma?
Kim S; Bull DA; Garland L; Khalpey Z; Stea B; Yi S; Hsu CC
Ann Thorac Surg; 2019 Jan; 107(1):194-201. PubMed ID: 30278171
[TBL] [Abstract][Full Text] [Related]
16. Disparities in Survival Due to Social Determinants of Health and Access to Treatment in US Patients With Operable Malignant Pleural Mesothelioma.
Alnajar A; Kareff SA; Razi SS; Rao JS; De Lima Lopes G; Nguyen DM; Villamizar N; Rodriguez E
JAMA Netw Open; 2023 Mar; 6(3):e234261. PubMed ID: 36951862
[TBL] [Abstract][Full Text] [Related]
17. Contemporary Analysis of Prognostic Factors in Patients with Unresectable Malignant Pleural Mesothelioma.
Billé A; Krug LM; Woo KM; Rusch VW; Zauderer MG
J Thorac Oncol; 2016 Feb; 11(2):249-55. PubMed ID: 26845118
[TBL] [Abstract][Full Text] [Related]
18. Malignant pleural mesothelioma incidence and survival in the Republic of Ireland 1994-2009.
Jennings CJ; Walsh PM; Deady S; Harvey BJ; Thomas W
Cancer Epidemiol; 2014 Feb; 38(1):35-41. PubMed ID: 24394956
[TBL] [Abstract][Full Text] [Related]
19. Gender-based Disparities in Receipt of Care and Survival in Malignant Pleural Mesothelioma.
Barsky AR; Ahern CA; Venigalla S; Verma V; Anstadt EJ; Wright CM; Ludmir EB; Berlind CG; Lindsay WD; Grover S; Cengel KA; Simone CB
Clin Lung Cancer; 2020 Nov; 21(6):e583-e591. PubMed ID: 32611504
[TBL] [Abstract][Full Text] [Related]
20. Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort.
Brosseau S; Danel C; Scherpereel A; Mazières J; Lantuejoul S; Margery J; Greillier L; Audigier-Valette C; Gounant V; Antoine M; Moro-Sibilot D; Rouquette I; Molinier O; Corre R; Monnet I; Langlais A; Morin F; Bergot E; Zalcman G; Levallet G
Clin Lung Cancer; 2019 Sep; 20(5):e564-e575. PubMed ID: 31279641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
